- Home
- VHI vs ORIC Comparison
VHI vs ORIC Comparison
Compare VHI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHI
- ORIC
- Stock Information
- Founded
- VHI 1932
- ORIC 2014
- Country
- VHI United States
- ORIC United States
- Employees
- VHI N/A
- ORIC N/A
- Industry
- VHI Major Chemicals
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- VHI Industrials
- ORIC Health Care
- Exchange
- VHI Nasdaq
- ORIC Nasdaq
- Market Cap
- VHI 453.6M
- ORIC 362.9M
- IPO Year
- VHI N/A
- ORIC 2020
- Fundamental
- Price
- VHI $17.74
- ORIC $5.08
- Analyst Decision
- VHI Sell
- ORIC Strong Buy
- Analyst Count
- VHI 1
- ORIC 8
- Target Price
- VHI $20.00
- ORIC $18.83
- AVG Volume (30 Days)
- VHI 9.3K
- ORIC 630.2K
- Earning Date
- VHI 05-08-2025
- ORIC 05-05-2025
- Dividend Yield
- VHI 1.77%
- ORIC N/A
- EPS Growth
- VHI 4465.30
- ORIC N/A
- EPS
- VHI 4.11
- ORIC N/A
- Revenue
- VHI $2,101,400,000.00
- ORIC N/A
- Revenue This Year
- VHI $22.20
- ORIC N/A
- Revenue Next Year
- VHI $7.66
- ORIC N/A
- P/E Ratio
- VHI $4.41
- ORIC N/A
- Revenue Growth
- VHI 6.57
- ORIC N/A
- 52 Week Low
- VHI $14.20
- ORIC $3.90
- 52 Week High
- VHI $41.75
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- VHI 57.48
- ORIC 44.71
- Support Level
- VHI $16.75
- ORIC $4.52
- Resistance Level
- VHI $18.43
- ORIC $5.83
- Average True Range (ATR)
- VHI 0.63
- ORIC 0.52
- MACD
- VHI 0.21
- ORIC 0.07
- Stochastic Oscillator
- VHI 75.30
- ORIC 40.58
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.